AAAAAA

   
Results: 1-11 |
Results: 11
ESTRADIOL AND PROGESTERONE REGULATE THE PROLIFERATION OF HUMAN BREASTEPITHELIAL-CELLS
Authors: FOIDART JM COLIN C DENOO X DESREUX J BELIARD A FOURNIER S DELIGNIERES B
Citation: Jm. Foidart et al., ESTRADIOL AND PROGESTERONE REGULATE THE PROLIFERATION OF HUMAN BREASTEPITHELIAL-CELLS, Fertility and sterility, 69(5), 1998, pp. 963-969
POSITION OF THE ON-NATIONALE-DES-CENTRES-DE-LUTTE-CONTRE-LE-CANCER (JULY 3, 1998)
Authors: EISINGER F ESPIE M KUTTENN F LASSET C DELIGNIERES B NAMER M ROCHE H SASCO A SERIN D PHILIP T
Citation: F. Eisinger et al., POSITION OF THE ON-NATIONALE-DES-CENTRES-DE-LUTTE-CONTRE-LE-CANCER (JULY 3, 1998), Bulletin du cancer, 85(8), 1998, pp. 725-725
HORMONE REPLACEMENT THERAPY - CLINICAL BENEFITS AND SIDE-EFFECTS
Authors: DELIGNIERES B
Citation: B. Delignieres, HORMONE REPLACEMENT THERAPY - CLINICAL BENEFITS AND SIDE-EFFECTS, Maturitas, 23, 1996, pp. 31-36
SAFETY OF COMBINED ORAL-CONTRACEPTIVE PILLS
Authors: DELIGNIERES B
Citation: B. Delignieres, SAFETY OF COMBINED ORAL-CONTRACEPTIVE PILLS, Lancet, 347(9000), 1996, pp. 548-549
PROGESTERONE CONCENTRATIONS - PHYSIOLOGICAL OR PHARMACOLOGICAL - REPLY
Authors: CHANG KJ DELIGNIERES B
Citation: Kj. Chang et B. Delignieres, PROGESTERONE CONCENTRATIONS - PHYSIOLOGICAL OR PHARMACOLOGICAL - REPLY, Fertility and sterility, 65(5), 1996, pp. 1077-1078
INFLUENCE OF ROUTE OF ADMINISTRATION ON PROGESTERONE METABOLISM
Authors: DELIGNIERES B DENNERSTEIN L BACKSTROM T
Citation: B. Delignieres et al., INFLUENCE OF ROUTE OF ADMINISTRATION ON PROGESTERONE METABOLISM, Maturitas, 21(3), 1995, pp. 251-257
INFLUENCES OF PERCUTANEOUS ADMINISTRATION OF ESTRADIOL AND PROGESTERONE ON HUMAN BREAST EPITHELIAL-CELL CYCLE IN-VIVO
Authors: CHANG KJ LEE TTY LINARESCRUZ G FOURNIER S DELIGNIERES B
Citation: Kj. Chang et al., INFLUENCES OF PERCUTANEOUS ADMINISTRATION OF ESTRADIOL AND PROGESTERONE ON HUMAN BREAST EPITHELIAL-CELL CYCLE IN-VIVO, Fertility and sterility, 63(4), 1995, pp. 785-791
THE CASE FOR A NONPLASMA LIPOPROTEIN ETIOLOGY OF REDUCED VASCULAR RISK IN ESTROGEN REPLACEMENT THERAPY
Authors: DELIGNIERES B
Citation: B. Delignieres, THE CASE FOR A NONPLASMA LIPOPROTEIN ETIOLOGY OF REDUCED VASCULAR RISK IN ESTROGEN REPLACEMENT THERAPY, Current opinion in obstetrics & gynecology, 5(3), 1993, pp. 389-395
TRANSDERMAL DIHYDROTESTOSTERONE TREATMENT OF ANDROPAUSE
Authors: DELIGNIERES B
Citation: B. Delignieres, TRANSDERMAL DIHYDROTESTOSTERONE TREATMENT OF ANDROPAUSE, Annals of medicine, 25(3), 1993, pp. 235-241
TRANSDERMAL DIHYDROTESTOSTERONE THERAPY AND ITS EFFECTS ON PATIENTS WITH MICROPHALLUS
Authors: CHOI SK HAN SW KIM DH DELIGNIERES B
Citation: Sk. Choi et al., TRANSDERMAL DIHYDROTESTOSTERONE THERAPY AND ITS EFFECTS ON PATIENTS WITH MICROPHALLUS, The Journal of urology, 150(2), 1993, pp. 657-660
PREVENTION OF ENDOMETRIAL HYPERPLASIA BY PROGESTERONE DURING LONG-TERM ESTRADIOL REPLACEMENT - INFLUENCE OF BLEEDING PATTERN AND SECRETORY CHANGES
Authors: MOYER DL DELIGNIERES B DRIGUEZ P PEZ JP
Citation: Dl. Moyer et al., PREVENTION OF ENDOMETRIAL HYPERPLASIA BY PROGESTERONE DURING LONG-TERM ESTRADIOL REPLACEMENT - INFLUENCE OF BLEEDING PATTERN AND SECRETORY CHANGES, Fertility and sterility, 59(5), 1993, pp. 992-997
Risultati: 1-11 |